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Although research exists regarding barriers to mental health care for individuals 
with depression and anxiety disorders, few studies have compared characteristics of those 
who seek treatment versus those who do not seek treatment for psychological distress 
associated with these disorders.  Such studies are needed in order to better understand 
factors involved in treatment seeking and treatment abstention.  The present study 
addresses treatment seeking and treatment abstention in individuals with major 
depressive disorder (MDD) and generalized anxiety disorder (GAD), in order to 
understand barriers to treatment in this population.  Results indicate that the groups did 
not significantly differ on their gender, finances, sexual orientation, ethnicity, and grade 
classification. Results also suggest that those who seek treatment associate less stigma 
with mental health than those who do not seek treatment. Finally, both groups prefer to 
handle their own problems and think that their problems would eventually resolve 
themselves. These results may be helpful in informing outreach and prevention efforts 
targeted to an MDD and GAD population. 
 1 
 
Introduction 
 
There exists a very large treatment gap in the area of mental health disorders 
within the United States.  A treatment gap is defined as the number of people who need 
treatment but are not receiving it, even though effective treatment is available.  
Approximately 28% of Americans will suffer from an anxiety or depressive disorder 
(Kessler et al., 2005).  The treatment gap is approximately 68% for GAD and 72% for 
MDD (Kohn et al, 2004).  Indeed, a large percentage of people who need treatment are 
not receiving it with direct and indirect ramifications (Wang et al., 2005).  
Due to depressive disorders alone, lost productivity in the workforce accounts for 
a $23 billion cost to the United States annually (Kohn et al., 2004).  Wang, Simon, and 
Kessler (2003) reported that about 44% of those surveyed in the National Comorbidity 
Study (NCS) were absent for at least one day of work in the last three months due to 
complications regarding major depression.  Additionally, compared to disorder-free 
individuals, they were 27 times more likely to experience work loss (Wang et al., 2003).  
For GAD, Wittchen (2002) states that it may lead to complete disability, diminished 
productivity at work, and is as much of a burden on society as depression.  Moreover, 
individuals with comorbid GAD and MDD experience a higher level of disability 
(Wittchen, 2002).  In addition to GAD and MDD being problematic disorders when not 
comorbid, their comorbidity exacerbates economic costs to society. 
Untreated depressive and anxiety disorders also affect several aspects of an 
individual’s life, including personal and social domains.  Depressive disorders may affect 
2 
 
an individual’s workplace functioning, interpersonal relationships, marriage, educational 
achievement, and employment (Collins, Westra, Dozois, & Burns, 2004).  Children 
affected by anxiety disorders may have poor academic performance, a greater likelihood 
of being suspended, and run away from home (Collins et al., 2004).  Adults with anxiety 
disorders face problems in interpersonal relationships, including family interactions 
(Collins et al., 2004).  Despite efficacious treatment such as cognitive behavioral therapy 
and pharmacological options for anxiety and depressive disorders (Dobson, 1989), the 
treatment gap remains problematic. 
Literature Review 
A Closer Look at Treatment Barriers 
 There is currently a scarcity of data in the research literature pertaining 
specifically to individuals with MDD, GAD, and comorbid MDD/GAD and their 
respective barriers to treatment.  Table 1 lists the most common barriers to treatment 
seeking for anxiety and depression (Collins et al., 2004).  In order to narrow down the 
scope of this research project, only barriers on an individual level are examined.  
However, provider and systemic factors contribute to the overall treatment gap problem 
and will be considered further in the Discussion section.  
In addition to the barriers to treatment noted by Collins et al. (2004), Vogel, 
Wester, and Larson (2007) identified several general reasons why individuals with 
anxiety and depression may avoid counseling, referred to as “avoidance factors.” These 
barriers include social stigma, treatment fears, fear of emotion, anticipated utility and 
3 
 
risks, and self-disclosure.  More specifically, treatment fears are described as the fear of 
how one may be treated and viewed by a mental health professional which may delay or 
disrupt treatment-seeking behaviors.  Fear of emotion is described as the fear of 
discussing and experiencing painful emotions which may delay or disrupt treatment-
seeking behaviors.  Finally, anticipated utility and risks is described as the individual’s 
perception of how useful treatment will be, and whether the risks outweigh the benefits.  
It is important to note that Vogel et al. (2007) describe barriers to counseling whereas 
Collins et al. (2004) describe barriers to medication in addition to counseling for mental 
health problems.  
 The present study examines barriers to both medication and counseling using a 
student sample.  In a related study, Downs and Eisenberg (2012) examined treatment-
seeking behaviors and perceptions in a college sample endorsing suicidal ideation.  The 
researchers did not explicitly state whether their participants met criteria for MDD and/or 
GAD.  Still, suicidality is a common symptom among those with MDD and/or GAD, and 
there is a possibility that those who express suicidality may meet criteria for MDD and/ 
or GAD.  In fact, Downs and Eisenberg (2012) state that “9 out of 10 people who die by 
suicide in the United States have probable mental illnesses, and depressive symptoms 
have been associated with 95% of college students with reported suicidal ideation. ”  
Another important statistic that was reported is that less than half of students screening 
positive for depression or anxiety disorders received any mental health services in the last 
12 months.  It is evident that the researchers believe that there is a treatment gap among 
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the average college population suffering from depression and anxiety disorders, and that 
this gap can lead to suicidal ideation.  
In the Downs and Eisenberg (2012) study, participants were asked to rate their top 
barriers to treatment.  The majority of participants stated that they did not seek treatment 
because they preferred to deal with their own problems, perceived their stress as being 
“normal,” and questioned whether their problems warranted treatment.  Preferring to 
solve one’s own problems is a common trend in the treatment-seeking literature. This 
self-reliance is also reflected in a study completed by Meltzer et al. (2003).  However, in 
addition to participants reporting that they prefer to handle their own problems, in this 
study they also questioned the efficacy of treatment, worried about social stigma, and 
thought that their problems would eventually improve without treatment.  Overall, it 
appears that a lack of insight into the chronicity and severity of mental health issues can 
be a major barrier for treatment seeking (Meltzer et al., 2003).  Furthermore, high 
personal stigma was correlated with a lower perceived need for help in an untreated 
population (Schomerus et al., 2012). 
What other factors should be considered?  In a study that involved approximately 
347 adults living in Great Britain, Meltzer et al. (2003) found that socio-demographic and 
socioeconomic factors were not largely correlated with a reluctance to seek treatment.  
Instead, the researchers discovered that symptom severity played a more important role in 
seeking treatment.  Counterintuitively, the more severe the symptoms, the more likely it 
was for participants to express reluctance.  One important caveat of this study is that the 
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researchers only interviewed participants who “had not been to see a doctor when they or 
their family and friends thought they should” within the past year.  Participants who did 
not seek treatment because they did not perceive a need were not interviewed. This is an 
important distinction because a lack of knowledge about disorders has been found to be a 
barrier to treatment seeking. Another caveat is that the researchers collapsed ethnicity 
into four distinct categories: White, Black (African, African-Caribbean, and ‘Black 
Other’), South Asian (Indian, Pakistani, and Bangladeshi), and ‘Other.’  There could be 
differences within these groups that should be examined. Of those participants who did 
endorse a reluctance to seek treatment, two of the most common reasons given were 
“…not thinking anyone could help,” and “…a problem one should be able to cope with.”  
This study, despite the caveats mentioned, present another facet to the treatment gap 
problem.  That is, the severity of an individual’s mental health problems may contribute 
to their unwillingness to seek help despite needing it.  
 Phillips, Mayer, and Aday (2000) reported disparities in treatment barriers for 
different racial/ethnic groups in the United States in a separate study.  The study states 
that minorities, especially Hispanics, reported barriers more frequently than non-Hispanic 
whites.  Hispanics were most likely to endorse problems in obtaining care compared to 
other racial/ethnic groups.  Asian Americans were most likely to report dissatisfaction 
with the quality of care received.  The authors suggest that continuity of care may be a 
problem in this group.  African Americans more frequently reported barriers than non-
Hispanic whites, but less so than other racial/ethnic groups.  Individuals with insurance, 
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across all racial/ethnic groups, reported fewer barriers to care but “insurance alone did 
not guarantee better access to care” (Phillips et al., 2000).  In fact, about two-thirds of 
families who reported having barriers to care were insured. This study highlights the 
importance of examining cultural barriers that racial/ethnic populations may face when 
attempting to access care.  Although having insurance and the ability to pay is important, 
being insured is not a guarantee for a high quality of treatment.  Researchers and 
advocators must also look  at stigma, language, cultural, and socioeconomic barriers—
combined—in order to fully comprehend the needs of these populations. 
In addition to investigating barriers to treatment, examining characteristics of 
individuals who display positive treatment-seeking behaviors (i.e., those who seek 
treatment) should be examined as well in order to develop a better understanding of what 
motivates treatment seeking.  In the current literature, there is a paucity of data examining 
attitudes and beliefs of treatment seekers for MDD and/or GAD.  However, Thomas, 
Caputi, and Wilson (2014) found several attitudinal factors that may predict positive 
treatment-seeking behavior in an undergraduate sample of psychology students who 
experienced distress.  Their results indicate two attitudes that were endorsed by 
participants who intended to seek treatment for psychological distress: “If I believe that I 
was having a mental breakdown, my first thought would be to get professional attention,” 
and, “A person with an emotional problem is not likely to solve it alone; he or she is 
likely to solve it with professional help.”  As previously noted, two common barriers to 
treatment seeking include a lower perceived need for help and the desire to solve one’s 
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own problems.  The results from this study indicate that those who intended to seek 
treatment were more likely to do so if they perceived a need for help and believed that 
one is unlikely to resolve one’s own mental health problems.  
Research Questions and Hypotheses 
The present study’s focus was to examine common barriers to treatment amongst 
a student sample meeting criteria for MDD and/or GAD by exploring differences 
between treatment seekers and non-treatment seekers.  The goal of the study was to 
identify demographic, attitudinal, and other barriers in accessing care that could be 
targeted for change and could inform future outreach efforts.  
Demographic Differences. Are there demographic differences between the 
treatment and non-treatment seeking groups? For example, are treatment seekers more 
likely to be female? How does age, grade classification, sexual orientation, ethnicity, and 
symptom severity factor in?  Results might indicate that participants belonging to certain 
demographic groups are more or less likely to seek treatment than others. This 
information would help inform advocacy groups and also help as a starting point for 
outreach efforts. 
Attitudinal Differences. Another purpose of this study was to find differences in 
attitudes between treatment and non-treatment seekers. Attitudes are defined as a way of 
thinking about mental health and people who have mental health problems for the 
purpose of this study. Negative attitudes about mental health, for example, includes 
thinking that seeking treatment makes an individual less likable or that a person who 
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seeks treatment is weak. A positive attitude includes thinking that seeking treatment is a 
sign of personal strength, or that one would be friends with someone with a mental health 
problem.  
Other Barrier Differences. In addition to demographic and attitudinal barriers, 
other barriers will also be examined. One example of a barrier that could inhibit treatment 
seeking is holding a belief that one can handle one’s own problems. In fact, a previous 
study found that non-treatment seekers prefer to handle problems on their own and are 
less likely to seek treatment (Downs & Eisenberg, 2012; Meltzer et al., 2003).  
Results from this study may be helpful in changing perceptions of treatment and 
mental health in individuals experiencing mental health symptoms as well as in their 
friends and families.  For instance, if results indicate that those with MDD and/or GAD 
are less likely to seek treatment if they perceive treatment in a negative light or that they 
can handle their own issues, then mental health advocates can target those specific 
perceptions through various outreach campaigns (e.g., TV public service announcements, 
university and community awareness and outreach days, local and national support 
groups). In conclusion, results from this study may contribute to increasing mental health 
literacy and educating the public about the effectiveness of treatment while lessening the 
associated stigma of treatment for mental health issues. 
 
 
 
9 
 
Method 
Participants 
 A total of 549 undergraduate participants were screened via a Qualtrics online 
questionnaire (87 in Fall 2013, 133 in Spring 2014, 202 in Fall 2014, 127 in Spring 
2015).  Thirty-five participants met criteria based on meeting cut-off scores on two or 
more prescreening questionnaires (discussed further below) and were invited to complete 
a clinical interview using the Mini-International Neuropsychiatric Interview Plus 6.0 
(Sheehan et al., 1998) in order to verify diagnostic status.  These 35 participants were 
also asked to complete several questionnaire measures of treatment-seeking attitudes and 
behaviors.  Participants ranged in age from 18 to 64.  This study is IRB-approved and all 
participants must consent to participate before engaging in the study. 
Procedure 
Phase One.  In the first phase, students were asked to complete multiple 
screening questionnaires assessing their current and past symptomatology.  Based on 
these scores, students who met criteria were asked to participate in the second phase of 
the study which included a structured diagnostic interview.  Specifically, two 
questionnaires were used to screen for worry symptoms in the initial phase of the study: 
the Penn State Worry Questionnaire (PSWQ; Meyer, Miller, Metzger, & Borkovec, 1990; 
Molina & Borkovec, 1994; Behar et al., 2003; Fresco et al., 2003) and the Generalized 
Anxiety Disorder seven-question assessment (GAD-7; Spitzer, Kroenke, Williams, & 
Lowe, 2006).  Two questionnaires were also used to screen for depression:  an 8-item 
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subset of the Anhedonic Depression subscale of the Mood and Anxiety Symptom 
Questionnaire (MASQ; Watson, Clark, et al., 1995; Watson, Weber, et al., 1995; 
Nitschke, Heller, Imig, McDonald, & Miller, 2001) as well as the revised Center for 
Epidemiologic Studies-Depression Scale (CESD; Radloff, 1977; CESD-R; Eaton et al., 
2004).  The prescreening questionnaires took approximately 30 minutes to complete.  
Anxiety Measures.   
Penn State Worry Questionnaire.  The PSWQ is a 16-item questionnaire designed 
to measure chronic worry.  In a college sample, the PSWQ had high internal consistency 
(coefficient alphas = .92), and stability over time.  Correlations for test-retest stability of 
the PSWQ ranged from r = .75 to r = .92 over several time intervals (2 weeks, 4 weeks, 
and 8-10 weeks – Behar et al., 2003). Most importantly, the questionnaire distinguishes 
anxious samples from non-anxious samples.  Overall, the PSWQ is an effective measure 
for assessing “clinically significant, pathological worry” in a college population (Molina 
& Borkovec, 1994).  The present study uses a cut-off score of 62, as suggested by Behar, 
Alcaine, Zuellig, and Borkovec (2003). 
 Generalized Anxiety Disorder-7-Questionnaire.  Another measure that the present 
study uses for measuring anxiety is the GAD-7.  The GAD-7, is a 7-item questionnaire 
measuring anxiety symptoms typical of GAD.  In a study assessing symptoms in a 
population undergoing addictions treatment, Delgadillo et al. (2012) found that the GAD-
7 demonstrated high internal consistency (Cronbach’s alpha = 0.91).  Additionally, a 
GAD-7 score of 9 or greater had a sensitivity of 80% and specificity of 86% for any 
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anxiety disorder.  In other words, the questionnaire was sensitive enough to detect most 
participants who had an anxiety disorder, while being specific enough to target only those 
with GAD.  In a separate study, of more than 2,500 people assessed, the GAD-7 was 
found to have high sensitivity and specificity with a cut-off score of 10 or greater, and 
was found to have good reliability and validity (Spitzer et al., 2006).  Overall, the GAD-7 
is an effective and valid tool for screening anxious symptoms that are characteristic of 
GAD (Spitzer et al., 2006; Delgadillo et al., 2012).  The present study uses a cut-off score 
of 10, as suggested by Spitzer et al., 2006. 
Depression Measures. 
Mood and Anxiety Symptom Questionnaire Anhedonia Subscale.  The MASQ-AD 
8 is an 8-item subset of the Anhedonic Depression subscale of the Mood and Anxiety 
Symptom Questionnaire.  The scale is cited as having good convergent and discriminant 
validity in undergraduate samples (Bredemeier et al., 2010).  Additionally, the scale 
reliably predicted whether participants met criteria for a current Major Depressive 
Episode.  In the present study, the MASQ-AD 8 was used to screen for current and past 
MDE.  The instructions were slightly altered so that participants would frame their 
answers either during the past week (for current) or prior to that period (for past).  A cut-
off score of 23 achieves a balance of sensitivity and specificity (Bredemeier et al., 2010) 
and was used as the cut-off score in the present study. 
Center for Epidemiologic Studies-Depression Scale Revised.  The CESD-R was 
also used to measure depression symptoms.  The CESD-R is a revision of the original 
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CESD scale and has been shown to be as reliable and valid as the original scale. One 
advantage is that this revised scale is “more relevant to the current definitions of major 
depression” (Eaton et al., 2004).  The researchers also attest to the CESD-R’s excellent 
internal reliability and face and construct validity. Furthermore the test-retest reliability 
and criterion validity of the CESD-R are “expected to be very good” (Eaton et al., 2004). 
The lowest score for having a possibility of meeting depression criteria is 16.  The 
present study uses a cut-off score of 16 or above. 
These questionnaires were selected based on their strong psychometric properties 
as evidenced by the current research literature.  Finally, the justification for using more 
than one measure per domain is to have greater confidence that participants will meet 
criteria based on a structured diagnostic interview. The structure diagnostic interview was 
used as another layer to understanding the participants’ symptoms. 
Phase Two.  After the initial screening step, qualifying participants were invited 
to participate in the second phase of the study (i.e., the post-screening) by email or phone.  
Once the subject agreed to participate, they were asked if they would consent to being 
audio recorded for training and supervisory purposes.  If they declined, the interview 
would continue without the audio recording.  No participants declined being recorded.  
After completing the interview, participants completed a computerized self-assessment 
including demographic and opinion-based questions relating to mental health and 
treatment seeking.  All participants were given an informational sheet advising them of 
13 
 
available mental health resources located in the local community at the conclusion of 
each phase two session. 
Structured Diagnostic Interview (MINI Plus 6). 
 MINI Plus 6.  Once a participant met criteria for either anxiety or depression 
domains, they were invited to an in-person one-on-one interview conducted by one of 
three trained graduate student researchers. Once the subject agreed to participate, they 
were asked to consent to being audio recorded for training and supervisory purposes.  
Each participant was administered the Mini-International Neuropsychiatric Interview 
Plus 6.0 brief structured diagnostic interview.   
Developers of the MINI conducted validity and reliability studies comparing it to 
the Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, 
Patient Edition and the Composite International Diagnostic Interview (SCID-I/P; First, 
M., Spitzer, R., Gibbon, M., & Williams, J., 2002; CIDI; Robins, et al., 1988).  Results 
from Sheehan et al. (1998) indicate that the MINI has validity and reliability properties 
that are similar to the SCID-I/P and CIDI.  However, one advantage is that it can be 
administered in a shorter duration.  This tool was chosen for its good psychometric 
properties and relatively short administration time.  
All participants were asked to disclose information about their mental health care 
history, their family’s mental health care history, and their attitudes and behaviors 
regarding treatment seeking in the post-screening survey.  An example of a question 
assessing a treatment-seeking attitude: “How satisfied are you with the effectiveness of 
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the psychotherapy or counseling that you received, if any?” For the actual survey used, 
please refer to the post-screening questionnaire in Appendix B.  
In addition to custom-designed questions that assess barriers in accessing mental 
health care, the Barriers to Access to Care Evaluation scale (BACE; Clement et al., 2012) 
was included as part of the post-screening questionnaire.  Participants were asked to rate 
how much a given factor might prevent them from seeking treatment.  For example: 
“Concern that I might be seen as weak for having a mental health problem” would be 
rated by a participant from “not at all” to “a lot.”  Please refer to the Appendix B for a 
copy of the full BACE questionnaire used in phase two.   
At the end of the post-screening, participants were thanked for their participation 
in the study.  Each participant was given an informational sheet with a list of available 
resources in the community.  Each participant was also compensated with a gift card in 
the amount of 15 dollars to 10 dollars, based on funds availability.  The post-screening 
session was expected to last one to two hours per participant.   
Data were analyzed using descriptive and inferential statistics on participants’ 
responses to the questionnaires and measurements.  Relationships between treatment 
seekers and non-treatment seekers were examined.  Separate t-tests comparing treatment 
seekers and non-treatment seekers on symptoms, ratings of level of functioning, and 
questionnaire measures of perceptions of stigma and treatment efficacy were conducted.  
The two groups were compared via chi square tests on demographic factors in order to 
assess whether groups differed on demographic factors.  
15 
 
Results 
 
Phase One Sample 
 
 Of the 549 participants screened for the study, 70% (n = 385) identified as 
White/Caucasian and 72% (n = 396) were female, both consistent with the race/gender of 
the undergraduate population majoring in psychology in the Psychology and Counseling 
department.  Freshman students comprised 40.6% (n = 223) of the sample. Please refer to 
Tables 2 through 6 for more demographic details.  
Phase Two Sample 
 Thirty-five participants were invited to the second phase of the study and 
successfully completed it. As mentioned above, these participants were administered the 
MINI Plus 6 diagnostic interview and then the treatment-seeking attitudes and behaviors 
questionnaire.  Of those administered the diagnostic interview, 12 participants met 
criteria for a history of Major Depressive Disorder, 12 for Generalized Anxiety Disorder, 
and 22 for another disorder (e.g., bipolar disorder, panic disorder with agoraphobia, 
PTSD, etc.).  Seven participants met no criteria for a disorder. Please refer to Table 11 for 
more information.  
Regarding trends in the treatment-seeking questionnaire, of the 35 participants, 25 
endorsed seeking medication, psychotherapy, or both (i.e., treatment seekers), and 10 
denied seeking any type of treatment (i.e., non-treatment seekers).  The treatment seekers 
sought services for problems with anxiety, depression, adjustment problems, and 
physiological problems such as insomnia.   
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Results of Demographic Differences. Regarding whether self-reported financial 
factors affected treatment seeking, there was no significant difference between the 
groups; 2(5, N = 35) = 6.83, p = .23. This result suggests that financial barriers did not 
seem to influence non-treatment seekers’ decision to not seek treatment. This result 
supports research in the literature concluding that a person’s finances is not the sole 
determinant of whether or not they seek treatment and that other factors should be 
examined (Phillips, Mayer, & Aday, 2000). There were no gender differences between 
the two groups, 2(1, N = 35) = .08, p = .77. Regarding ethnicity and grade classification, 
there was no significant difference between the groups; 2(4, N = 35) = 1.97, p = .74 and 
2(4, N = 35) = .89, p = .93, respectively. 
When examining whether there was a difference in treatment-seeking rates in 
those who had past and/or present MDD and those who did not, results suggest a 
difference. Those with MDD past and/or present (N = 12) were more likely to seek 
treatment than those without MDD past and/or present (N = 23); 2(1, N = 35) = 7.30, p = 
.007. These results were not found in the sample who had GAD. For the GAD sample, 
there was no significant difference between those who were diagnosed with GAD and 
those who were not in terms of their treatment-seeking rates; 2(1, N = 35) = .11, p = 
.735. A Chi-square test was conducted to test whether sexual orientation affected 
treatment seeking. Results indicate that, in this sample, participants’ sexual orientation 
did not significantly affect treatment-seeking rates; 2(4, N = 35) = 6.94, p = .139. Please 
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refer to Tables 12 – 16 for more information. Finally, to test whether symptom severity 
had an impact on treatment seeking behaviors, the present study assigned each phase two 
participant a Global Assessment of Functioning score (GAF). Results from an 
independent samples t-test analysis indicated no significant difference between the 
groups and their GAF scores; t (33) = 1.18, p = .246. 
Results of Attitudinal Differences.  Treatment seekers differed from non-
treatment seekers on their self-report of the influence of stigma as measured by our six 
items stigma questionnaire (a list of these questions can be found in Appendix B, 
question 9.1). An independent samples t-test was conducted to compare how each group 
responded to stigma items. The results indicate that there was a significant difference in 
how much treatment seekers (M = 2.23, SD = .44) and non-treatment seekers (M = 2.62, 
SD = .37) attached stigma to mental health treatment; t (33) = 2.49, p = .02. This result 
indicates that non-treatment seekers attach slightly but reliably more stigma to mental 
health treatment than do treatment seekers in this sample. A subscale of the BACE was 
also used to tap into the stigma construct. An independent samples t-test was conducted 
on the means of participants’ scores on a stigma subscale of the BACE.  These questions 
gauged how much stigma acted as a barrier to treatment seeking. Results indicated that 
there was no significant difference in the way that treatment seekers (M = .87, SD = .64) 
and non-treatment seekers (M = .74, SD = .51) answered these questions; t(33) = .56, p = 
.58. This result suggests that this sample did not vary in their responses regarding 
whether stigma affects their treatment seeking rates. 
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In addition to stigma, participants were also assessed on their attitudes regarding 
the efficacy of medications, psychotherapy, and both medications and psychotherapy 
together, for people their age. An independent samples t-test conducted on the groups 
indicate that there that is no significant difference in how effective treatment seekers and 
non-treatment seekers perceived medication t(33) = 1.05, p = .302, psychotherapy t(33) = 
.53, p = .597, and both combined t(33) = .51, p = .615. Thus, when asked about the 
efficacy of each type of treatment for people their age, treatment seekers and non-
treatment seekers did not significantly differ in their answers.  
Results of Barrier Differences.  There was no significant difference on the mean 
of all BACE questions for treatment seekers (M = 89, SD = .46) versus non-treatment 
seekers (M = .92, SD = .37); t(33) = -.14, p = .89. When looking at these results, one 
might conclude that, although non-treatment seekers attach more stigma to mental health 
than treatment seekers as measured by the six item stigma questionnaire, it is not a 
significant treatment barrier for them. However, the six item stigma questionnaire 
assessed the amount of stigma participants attached to mental health in general while the 
BACE stigma subscale measured whether stigma was a barrier to treatment seeking.  
 On the BACE scale, participants rated each barrier on a scale from 0 to 3 (with 0 
being not at all concerned and 3 indicating “a lot” of concern).  The top three barriers for 
treatment seekers were: Wanting to solve the problem on my own (N = 25, M = 1.76, SD 
= 1.09), thinking the problem would get better by itself (N = 25, M = 1.56, SD = .92), and 
concern about what my family might think, say, do or feel (N = 25, M = 1.36, SD = 1.22).  
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Of the non-treatment seeking participants, the top three barriers were: Wanting to solve 
the problem on my own (N = 10, M = 2.60, SD = .70), dislike of talking about my 
feelings, emotions or thoughts (N = 10, M = 1.60, SD = .97), and thinking the problem 
would get better by itself (N = 10, M = 1.40, SD = 1.17). Please note that both treatment 
seekers and non-treatment seekers reported “wanting to solve the problem on my own” 
and “thinking the problem would get better by itself” as two of their top three barriers, 
out of a list of 30 possible barriers. 
Discussion 
By understanding how individuals view treatment seeking, the mental health 
community may be better equipped to inform policy, increase mental health literacy, and 
diminish the treatment gap.  Individuals who seek and receive adequate treatment 
experience an improvement in their quality of life. Remission rates in depression and 
GAD are low, and these disorders tend to be chronic in nature. In addition, future public 
tragedies could be prevented if more people affected by mental health problems sought 
treatment.  One major aim of this research study was to provide an additional layer of 
understanding on the topic of treatment-seeking attitudes and behaviors.      
The data collected thus far suggests many similarities and differences between 
treatment and non-treatment seekers.  For example, both treatment and non-treatment 
seekers had similar ratings for the perceived helpfulness of medications, psychotherapy, 
and medication/psychotherapy combined.  Both groups also agreed that psychotherapy is, 
in general, more helpful than medications for individuals of their age.  Another similarity 
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exists in the participants’ attitude towards stigma.  There was a trend for both groups to 
have very low levels of personal stigma towards those who receive mental health 
treatment.  However, many participants think that others do not think very highly of 
people with a mental health problem based on how participants rated the items on the 9.1 
stigma questions.  This discrepancy between personal and public stigma can help explain 
the treatment gap.  Misperceptions about how the general public views those with a 
mental health problem can stifle treatment seeking behaviors.  It is very interesting that 
individual perceptions about mental health may be shifting towards less stigmatization, 
yet individuals are worried the general public may not think highly of those who receive 
mental health treatment.  
Another finding is that non-treatment seekers differed significantly from 
treatment seekers in the way that they responded to a set of questions measuring how 
much stigma they attached to mental health (i.e., the six item stigma questionnaire). 
Treatment seekers, on average, attached less stigma to mental health than did non-
treatment seekers based on results from the six item stigma questionnaire. However, the 
groups did not differ significantly in their responses regarding stigma on a subset of 
questions in another measure (BACE). One possible explanation for this discrepancy is 
that the six item stigma questionnaire measured directly how much stigma participants 
attached to mental health. The other set of questions, the BACE stigma subscale, gauged 
how much stigma acted as a barrier for participants. This difference in how the questions 
are worded could explain why there is a discrepancy. Furthermore, participants might 
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attach stigma to mental health but this attachment alone does not act as a barrier to 
treatment seeking. 
 While mental health stigma alone does not explain the reason for the treatment 
gap in the present study, perhaps additional factors might provide more clarity. Gender, 
sexual orientation, ethnicity, grade classification, availability of funds, and symptom 
severity were examined to determine their impact on treatment seeking. Results from this 
study indicate that participants did not differ in each of these categories. It is interesting 
that there was no significant difference in gender composition in the treatment seeking vs. 
non-seeking groups. However, more female than male participants in both groups reflects 
the college sample that was surveyed (with more female than male psychology majors).  
In addition to these demographic factors, we also examined if there was a 
significant difference in the amount of participants with MDD or GAD who sought 
treatment. Every participant with a diagnosis of MDD past and/or present in our sample 
reported being a treatment seeker. With GAD, there was no significant difference in the 
amount of treatment versus non-treatment seekers. This result suggests that those 
diagnosed with or meeting criteria for MDD are more likely to seek treatment than those 
meeting criteria for GAD. Perhaps it is the case that depression is more well-known than 
GAD; advertisements for depression medication far outnumber the ones for anxiety. 
Additionally, the symptoms of GAD might be erroneously attributed to personality traits 
rather than to a treatable disorder. Another interpretation, given the population of our 
college sample, is that high anxiety and worry are considered norms, and thus 
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participants preferred to resolve their anxiety problems on their own without seeking 
treatment. 
This study is only a small piece of the puzzle and other important pieces include 
systemic- and provider-level barriers. For instance, if participants are not aware of 
available resources in their community, then it is logical that they will not successfully 
receive treatment for their mental health issues. Likewise, if a primary care physician 
does not refer them to appropriate resources, then the individual might not receive the 
services they need. A future direction of this study might aim to encapsulate additional 
levels of barriers, such as the systemic and provider levels.   
One major limitation of the sample is lack of power associated with a relatively 
small sample size.  While treatment seekers comprised 25 of the 35 participants in phase 
2, non-treatment seekers comprised 10. Several efforts have been made to increase the 
amount of non-treatment seekers in the sample, but overall this group has been 
challenging to recruit. Another limitation of this study is that recruitment is confined to a 
university sample.  However, the sample does have clinically significant anxiety and/or 
depression and the majority met DSM criteria for GAD and/or MDD, ensuring 
generalizability to the wider population of GAD and MDD.  Another limitation lies in the 
nature of self-reported data.  Data self-reported by participants on the questionnaires and 
in the interview was not independently verified for accuracy (e.g., against the 
participant’s medical or mental health records) in the present study due to feasibility and 
privacy issues.  
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Findings from this study suggest that screening for mental health symptoms in the 
college population is important. Those with GAD, for example, might not know that they 
have a treatable condition. Screenings will provide insight into their symptoms. Then, 
those scoring highly on the screenings should be encouraged to seek treatment with the 
appropriate referrals. In addition to screenings, mental health professionals and other 
advocates can educate the public about mental health stigma to dispel the commonly held 
belief that seeking treatment means that one is weak or unable to handle one’s own 
problems. After all, participants, as a whole, endorsed as a top barrier in the present study 
that they preferred to handle their own problems. For non-treatment seekers, they also 
endorsed that they did not like to discuss their emotions and feelings, and that they 
thought their problems would eventually get better with time. Screeners and outreach 
members can educate participants about the chronic course of untreated mental health 
disorders and about the beneficial effects of mental health treatment. 
 Despite the current limitations, results should contribute to the literature 
regarding how individuals meeting criteria on prescreening measures for MDD and GAD 
conceptualize treatment-seeking behaviors.  This information can be used to inform 
mental health practitioners as well as individuals suffering from GAD and MDD 
regarding barriers and motivators for treatment.  Ultimately, this work could also be 
incorporated into future research, outreach, and intervention efforts. An increase of 
treatment seekers could mean an increase in those who receive adequate treatment, 
leading to more people who are healthy and productive members of society.  
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Table 1.  Barriers to Treatment for Anxiety and Depression 
Level Barrier 
Individual 
 
 
 
 
 
 
Provider 
 
 
 
Systemic 
Willingness to disclose problems 
Fear of stigma and embarrassment 
Lack of time for treatment 
Negative stereotypes of treatment 
Presence of comorbid medical problems 
Cultural factors 
Demographic factors (age, marital status) 
Geographic influences 
Desire to handle problems on one’s own 
Lack of awareness of available treatment 
Minimizing severity of problems 
Degree of distress and disruption of symptoms 
Readiness for change 
 
Underdetection within primary care sector 
Lack of knowledge of mental health problems 
Preoccupation with possible organic pathology 
Skill in assessing mental health difficulties 
Busyness and structure of practice 
Willingness to diagnose and treat mental health issues 
Stigma regarding discussing mental health issues 
Somatizing patient presentation style 
 
Level of distress in presentation 
Limited physician access to mental health services 
Lack of awareness of range of effective treatment options 
Primary care guidelines emphasizing pharmacotherapy 
Limited availability of specialty mental health providers 
Lack of integration of mental health services in primary 
care 
Low rates of provision of evidence-based care in mental 
health services 
Limited training in evidence-based care among mental 
health training programs 
Limited response rates to empirically supported 
treatments 
Collins et al., 2004  
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Table 2.  Racial and Ethnic Distribution of Phase Sample 
 
  Frequency Percent 
Valid 
Percent 
American 
Indian/ 
Alaska 
Native 
7 1.3 1.3 
Unknown 
or prefer 
not to 
report 
 
18 3.3 3.3 
Asian 36 6.6 6.6 
Black or 
African 
American 
 
49 8.9 8.9 
Other or 
multiracial 
54 9.8 9.8 
White 385 70.1 70.1 
Total 549 100.0 100.0 
 
Table 3.  Age Distribution of Phase One Sample 
 
  Frequency Percent 
Valid 
Percent 
13-17 3 .5 .5 
55-64 3 .5 .5 
35-54 18 3.3 3.3 
26-34 27 4.9 4.9 
18-25 498 90.7 90.7 
Total 549 100.0 100.0 
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Table 4.  Gender Distribution of Phase One Sample 
  Frequency Percent 
Valid 
Percent 
Prefer 
not to 
report 
 
2 .4 .4 
Male 151 27.5 27.5 
Female 396 72.1 72.1 
Total 549 100.0 100.0 
 
Table 5.  Grade Classification of Phase One Sample 
   
  Frequency Percent 
Valid 
Percent 
Graduate 
student 
2 .4 .4 
Other (e.g. 
non-degree 
student) 
6 1.1 1.1 
Senior 73 13.3 13.3 
Junior 
 
120 21.9 21.9 
Sophomore 
 
125 
 
22.76867 
 
22.76867 
 
Freshman 
or first-year 
student 
223 40.6 40.6 
Total 549 100.0 100.0 
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Table 6. Language Ability of Phase One Sample 
 
   Frequency Percent 
Valid 
Percent 
Restricted ability 
(e.g., only reading or 
only 
speaking/listening) 
1 .2 .2 
Some familiarity 
(e.g., a year of 
instruction in school) 
1 .2 .2 
Limited but 
adequate 
competence in 
speaking, reading, 
and writing 
3 .5 .5 
Fully competent in 
speaking, listening, 
reading, and writing, 
but not native 
85 15.5 15.5 
Native (learned from 
birth) 
459 83.6 83.6 
Total 549 100.0 100.0 
 
Table 7.  Descriptive Statistics of Test Scores of Phase One Sample  
 
 N Minimum Maximum Mean Std. Deviation 
CESDRSum 549 .00 55.00 14.8452 12.61631 
MASQPastSum 549 8.00 40.00 16.2550 6.27565 
MASQRecentSum 549 8.00 39.00 15.1038 6.19322 
GADSum 549 .00 21.00 6.8980 5.04800 
PSWQSum* 537 17.00 80.00 49.9944 14.06826 
Valid N (listwise) 537     
*A Qualtrics error at the onset of the study prevented some participants from taking the PSWQ. 
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Table 8. Means of Some Scales Used 
 
Did they seek 
treatment or not? 
N Mean Std. 
Deviation 
Std. Error 
Mean 
BACE_ToTalMeanValue 
Yes 25 .8933 .45612 .09122 
No 10 .9168 .37275 .11787 
BACE_meanTreatstigma 
 
Yes 
 
25 
 
.8700 
 
.64284 
 
.12857 
No 
 
10 .7417 .50834 .16075 
TreatmentStigmaRating 
 Yes 25 2.2267 .43536 .08707 
No 10 2.6170 .36898 .11668 
PSWQSum 
 
Yes 
25 63.4000 10.17349 2.03470 
No 10 62.9000 7.65143 2.41960 
GADSum 
 
Yes 
25 12.6400 3.32766 .66553 
No 10 12.4000 2.91357 .92135 
MASQRecentSum 
 
Yes 
25 23.5200 7.17705 1.43541 
No 10 23.3000 3.52924 1.11604 
MASQPastSum 
 
Yes 
25 22.3600 7.34212 1.46842 
No 10 22.6000 7.54542 2.38607 
CESDRSum 
 
Yes 
25 30.8800 11.49029 2.29806 
No 10 29.3000 8.84496 2.79702 
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Table 9. Independent Samples T-tests for the Total Mean of BACE and Stigma Items 
 
  
Levene's Test 
for Equality of 
Variances 
t-test 
for 
Equality 
of 
Means         
F Sig. t df 
Sig. (2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
BACE_ToTalMeanValue Equal 
variances 
assumed 
.823 .371 -.144 33 .886 -.02346 .16275 
Equal 
variances 
not 
assumed 
    -.157 20.281 .876 -.02346 .14905 
BACE_meanTreatstigma Equal 
variances 
assumed 
1.984 .168 .563 33 .577 .12833 .22791 
Equal 
variances 
not 
assumed 
    .623 20.978 .540 .12833 .20584 
TreatmentStigmaRating Equal 
variances 
assumed 
.770 .387 -2.494 33 .018 -.39033 .15651 
Equal 
variances 
not 
assumed 
    -2.681 19.542 .015 -.39033 .14559 
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Table 10. Independent Samples T-tests for Some Scales Used 
  
Levene's Test for 
Equality of 
Variances 
t-test for 
Equality 
of 
Means         
F Sig. t df 
Sig. (2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
PSWQSum Equal 
variances 
assumed 
.587 .449 .140 33 .890 .50000 3.57401 
Equal 
variances 
not 
assumed 
    .158 22.087 .876 .50000 3.16140 
GADSum Equal 
variances 
assumed 
1.357 .252 .199 33 .843 .24000 1.20482 
Equal 
variances 
not 
assumed 
    .211 18.912 .835 .24000 1.13658 
MASQRecentSum Equal 
variances 
assumed 
4.840 .035 .092 33 .927 .22000 2.39170 
Equal 
variances 
not 
assumed 
    .121 31.292 .904 .22000 1.81823 
MASQPastSum Equal 
variances 
assumed 
.011 .918 -.087 33 .931 -.24000 2.76812 
Equal 
variances 
not 
assumed 
    -.086 16.235 .933 -.24000 2.80171 
CESDRSum Equal 
variances 
assumed 
.801 .377 .390 33 .699 1.58000 4.05337 
Equal 
variances 
not 
assumed 
    .436 21.567 .667 1.58000 3.62000 
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Table 11. Frequencies of Diagnoses Made by the MINI Plus 6 
 
Diagnosis of MDD, Past or Present 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
yes 12 34.3 34.3 34.3 
no 23 65.7 65.7 100.0 
Total 35 100.0 100.0  
 
Diagnosis of GAD 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
yes 12 34.3 34.3 34.3 
no 23 65.7 65.7 100.0 
Total 35 100.0 100.0  
 
Diagnosis of Other, Past or Present 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
yes 22 62.9 62.9 62.9 
no 13 37.1 37.1 100.0 
Total 35 100.0 100.0  
 
Number Without a Diagnosis 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
yes 7 20.0 20.0 20.0 
no 28 80.0 80.0 100.0 
Total 35 100.0 100.0  
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Table 12. Chi-Square Test Comparing Groups and Their Finances 
 
Chi-Square Tests 
 Value df Asymp. Sig. (2-
sided) 
Pearson Chi-Square 6.825a 5 .234 
Likelihood Ratio 7.471 5 .188 
Linear-by-Linear Association 1.038 1 .308 
N of Valid Cases 35   
a. 11 cells (91.7%) have expected count less than 5. The minimum 
expected count is .57. 
 
 
 
Very poor, 
could not afford 
health 
insurance 
Enough to get 
by, but not 
enough for 
health 
insurance 
Comfortable, 
could afford 
health 
insurance 
Well to do, 
could afford 
health 
insurance 
Prefer not to 
answer 
I have never 
had emotional 
or mental health 
problems. 
T. Seeker 3 5 10 5 2 0 
Non-T. Seeker 1 1 5 1 0 2 
Total 4 6 15 6 2 2 
 
 
 
Table 13. Chi-Square Test Comparing Groups and Their Gender 
 
Chi-Square Tests 
 Value df Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square .080a 1 .777   
Continuity Correctionb .000 1 1.000   
Likelihood Ratio .079 1 .779   
Fisher's Exact Test    1.000 .564 
Linear-by-Linear Association .078 1 .780   
N of Valid Cases 35     
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a. 2 cells (50.0%) have expected count less than 5. The minimum expected count is 1.71. 
b. Computed only for a 2x2 table 
 
Count 
 Gender Total 
female male 
Did they seek treatment or 
not? 
Yes 21 4 25 
No 8 2 10 
Total 29 6 35 
 
Table 14.  Chi-Square Test Comparing Groups and MDD Past and/or Present 
Chi-Square Tests 
 Value df Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 7.304a 1 .007   
Continuity Correctionb 5.329 1 .021   
Likelihood Ratio 10.387 1 .001   
Fisher's Exact Test    .007 .006 
Linear-by-Linear Association 7.096 1 .008   
N of Valid Cases 35     
a. 1 cells (25.0%) have expected count less than 5. The minimum expected count is 3.43. 
b. Computed only for a 2x2 table 
 
Count 
 MDDPastorPresent Total 
yes no 
Did they seek treatment or 
not? 
Yes 12 13 25 
No 0 10 10 
Total 12 23 35 
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Table 15. Chi-Square Test Comparing Groups and GAD 
 
Chi-Square Tests 
 Value df Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square .114a 1 .735   
Continuity Correctionb .000 1 1.000   
Likelihood Ratio .116 1 .734   
Fisher's Exact Test    1.000 .530 
Linear-by-Linear Association .111 1 .739   
N of Valid Cases 35     
a. 1 cells (25.0%) have expected count less than 5. The minimum expected count is 3.43. 
b. Computed only for a 2x2 table 
 
Count 
 GADPastorPresent Total 
yes no 
Did they seek treatment or 
not? 
Yes 9 16 25 
No 3 7 10 
Total 12 23 35 
 
Table 16. Chi-Square Test Comparing Groups and Sexual Orientation 
Chi-Square Tests 
 Value df Asymp. Sig. (2-
sided) 
Pearson Chi-Square 6.939a 4 .139 
Likelihood Ratio 7.733 4 .102 
Linear-by-Linear Association .014 1 .904 
N of Valid Cases 35   
a. 8 cells (80.0%) have expected count less than 5. The minimum 
expected count is .57. 
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Count 
 What is your sexual orientation? Total 
Heterosexual Gay or 
Lesbian 
Bisexual Prefer not 
to answer 
Other 
(please 
specify) 
Did they seek 
treatment or not? 
Yes 19 0 2 1 3 25 
No 6 2 1 1 0 10 
Total 25 2 3 2 3 35 
 
Table 17. Chi-Square Test Comparing Groups and Ethnicity 
 
Chi-Square Tests 
 Value df Asymp. Sig. (2-
sided) 
Pearson Chi-Square 1.974a 4 .741 
Likelihood Ratio 2.759 4 .599 
N of Valid Cases 35   
a. 8 cells (80.0%) have expected count less than 5. The minimum 
expected count is .29. 
 
Crosstab 
Count 
 Ethnicity Total 
asian black or 
african 
american 
other or 
multiracial 
unknown or 
prefer not to 
report 
white 
Did they seek 
treatment or not? 
Yes 1 1 4 2 17 25 
No 0 1 1 0 8 10 
Total 1 2 5 2 25 35 
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Table 18. Chi-Square Test Comparing Groups and Grade Classification 
 
Chi-Square Tests 
 Value df Asymp. Sig. (2-
sided) 
Pearson Chi-Square .886a 4 .927 
Likelihood Ratio 1.146 4 .887 
N of Valid Cases 35   
a. 7 cells (70.0%) have expected count less than 5. The minimum 
expected count is .29. 
 
 
Crosstab 
Count 
 Classification Total 
freshman or 
first-year 
junior other (e.g., 
non-degree 
student) 
senior sophomore 
Did they seek 
treatment or not? 
Yes 9 6 1 2 7 25 
No 3 2 0 1 4 10 
Total 12 8 1 3 11 35 
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Table 19. Chi-Square Test Comparing Groups and GAF Scores 
 
Independent Samples Test 
 Levene's 
Test for 
Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df Sig. 
(2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
GAFScore 
Equal 
variances 
assumed 
2.898 .098 
-
1.181 
33 .246 -6.08000 5.15021 
-
16.55818 
4.39818 
Equal 
variances 
not 
assumed 
  
-
1.283 
20.062 .214 -6.08000 4.73802 
-
15.96137 
3.80137 
 
Group Statistics 
 
Did they seek treatment or 
not? 
N Mean Std. Deviation Std. Error Mean 
GAFScore 
Yes 25 74.1200 14.40289 2.88058 
No 10 80.2000 11.89584 3.76180 
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Appendix A. Phase One Questionnaire 
Name: ________________________________ 
Best contact email: _____________________________ 
Best contact number 
 Home phone ____________________ 
 Cell phone  _____________________ 
 
1. How old are you? 
 Under 13  
 13-17  
 18-25  
 26-34  
 35-54  
 55-64  
 65 or over  
 
2. What is your gender? 
 Male  
 Female 
 
3. What is your year in college? 
 Freshman or first-year student  
 Sophomore  
 Junior  
 Senior  
 Graduate student  
 Other (e.g. non-degree student)  
 
4. Which of the following best describes you? 
 Hispanic or Latino  
 Not Hispanic or Latino  
 Unknown or prefer not to report  
 
5. What is your racial background? 
 American Indian/ Alaska Native  
 Asian  
 Black or African American  
 Native Hawaiian or Other Pacific Islander  
 White  
 Other or multiracial  
 Unknown or prefer not to report  
 
6. Please rate your overall ability in the English language: 
 Native (learned from birth)  
45 
 
 Fully competent in speaking, listening, reading, and writing, but not native  
 Limited but adequate competence in speaking, reading, and writing  
 Restricted ability (e.g., only reading or only speaking/listening)  
 Some familiarity (e.g., a year of instruction in school)  
 
7. Over your lifetime, have you had any significant problems with work, school, or relationships due to a 
mental health problem? 
 No 
 Yes (please explain in 2 – 3 sentences):  
 
 Think back to a time when you struggled with mental health problems, if applicable. On a scale of 1 to 100, 
please rate your ability to handle day-to-day functions at that time in areas such as work, school, and 
relationships. (Note: 1 means that you were persistently incapable of handling life's problems, and 100 means that 
you operated at a level of superior functioning, and life's problems never seemed to get out of hand). 
 What is your rating? ___ 
 Not applicable 
 
 Have any physiological symptoms, like disturbed sleep and/or pains, ever kept you from functioning 
normally in areas such as work, school, or relationships?No 
 Yes (please explain in 2 – 3 sentences): 
 
8. Pick a number from the scale below that best describes how typical or characteristic each of the items is of 
you. There is no right or wrong answers. Indicate your answer for each statement by writing your choice on 
the blank next to that statement. 
 
  1                               2                             3                         4                             5 
Not at all typical                                          Somewhat typical                                       Very typical 
 
______ If I don't have enough time to do everything, I don't worry about it  
______ My worries overwhelm me.  
______ I don’t tend to worry about things.  
______ Many situations make me worry.  
______ I know I shouldn’t worry about things, but I just can’t help it.  
______ When I am under pressure, I worry a lot.  
______ I am always worrying about something.  
______ I find it easy to dismiss worrisome thoughts.  
______ As soon as I finish one task, I start to worry about everything else I have to do.  
______ I never worry about anything.  
______ When there is nothing more I can do about a concern, I don’t worry about it anymore.  
______ I’ve been a worrier all my life. 
______ I notice that I have been worrying about things.  
______ Once I start worrying, I can’t stop.  
______ I worry all the time.  
______ I worry about projects until they are done.  
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9. Over the last 2 weeks, how often have you been bothered by the following problems? There are no right or 
wrong answers. Indicate your answer for each statement by writing your choice on the blank next to that 
statement.  
 
 
0                   _____           1         ___                    2               ______          3                              
Not at all   Several days       More than half the days Nearly every day 
 
______ Feeling nervous, anxious, or on edge  
______ Not being able to stop or control worrying  
______ Worrying too much about different things  
______ Trouble relaxing  
______ Being so restless that it is hard to sit still  
______ Becoming easily annoyed or irritable  
______ Feeling afraid as if something awful might happen  
 
10. Below is a list of the ways you might have felt or behaved. Indicate how often you have felt this way in the 
past two weeks by writing your choice on the blank next to that statement. There are no right or wrong 
answers.  
 
 
0                                  1                                  2                                   3           ______             4 
   Not at all or                       1 – 2 days            3 – 4 days          5 – 7 days Nearly every day for 
2 weeks 
 less than 1 day 
______ My appetite was poor.  
______ I could not shake off the blues.  
______ I had trouble keeping my mind on what I was doing.  
______ I felt depressed.  
______ My sleep was restless.  
______ I felt sad.  
______ I could not get going.  
______ Nothing made me happy.  
______ I felt like a bad person. 
______ I lost interest in my usual activities.  
______ I slept much more than usual.  
______ I felt like I was moving too slowly.  
______ I felt fidgety. 
______ I wished I were dead.  
______ I wanted to hurt myself.  
______ I was tired all the time.  
______ I did not like myself. 
______ I lost a lot of weight without trying to.  
______ I had a lot of trouble getting to sleep.  
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______ I could not focus on the important things.  
 
11. Below is a list of feelings, sensations, problems, and experiences that people sometimes have. Indicate your 
answer for each statement by writing your choice on the blank next to that statement.  Use the choice that 
best describes how much you have felt or experienced things this way during the past week, including 
today.  
 
 
1                                  2                                  3                                  4           ______             5 
Not at all                                A little bit            Moderately         Quite a bit                       
Extremely 
 
______ Felt really slowed down  
______ Felt unattractive  
______ Felt withdrawn from other people  
______ Felt really bored   
______ Felt like it took extra effort to get started  
______ Felt like nothing was very enjoyable  
______ Felt like there wasn't anything interesting or fun to do  
______ Thought about death or suicide  
 
12. Below is a list of feelings, sensations, problems, and experiences that people sometimes have. Indicate your 
answer for each statement by writing your choice on the blank next to that statement.  Use the choice that 
best describes how much you have felt or experienced things this way during your lifetime, not including 
the past week.  
 
 
1                                  2                                  3                                  4           ______             5 
 Not at all                                A little bit            Moderately         Quite a bit                       
Extremely 
______ Felt really slowed down  
______ Felt unattractive  
______ Felt withdrawn from other people  
______ Felt really bored  
______ Felt like it took extra effort to get started  
______ Felt like nothing was very enjoyable  
______ Felt like there wasn't anything interesting or fun to do  
______ Thought about death or suicide  
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Appendix B. Phase Two Questionnaire 
Q2.1 Please read each question carefully before selecting your answer. 
 
Q2.2 Have you ever sought medications for emotional or mental health problems such as feeling sad, blue, 
anxious or nervous? 
 Yes (1) 
 No (2) 
 
Q2.3 Have you ever sought psychotherapy or counseling for emotional or mental health problems such as feeling 
sad, blue, anxious or nervous?  
 Yes (1) 
 No (2) 
 
Q2.4 What is your sexual orientation? 
 Heterosexual (1) 
 Gay or Lesbian (2) 
 Bisexual (3) 
 Prefer not to answer (4) 
 Other (please specify) (5) ____________________ 
 
Q2.5 If you have had emotional or mental health problems, how would you best describe your financial situation 
at or around the time when you had those problems? 
 Very poor, could not afford health insurance (1) 
 Enough to get by, but not enough for health insurance (2) 
 Comfortable, could afford health insurance (3) 
 Well to do, could afford health insurance (4) 
 Prefer not to answer (5) 
 I have never had emotional or mental health problems. (6) 
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Q3.1 Which of the following professional service provider(s) did you seek? Check all that apply. 
 Psychologist (1) 
 Psychiatrist (2) 
 Licensed Professional Counselor (3) 
 Licensed Clinical Social Worker (4) 
 Psychiatric Nurse Practitioner (5) 
 Physician/family doctor (6) 
 Registered Nurse (7) 
 Other (please specify) (8) ____________________ 
 
Q3.2 How long ago was your most recent visit to a professional service provider for help? If you cannot 
remember or if you did not seek a professional service provider, check N/A. 
 In the last 6 months (1) 
 Between 7 months to 1 year ago (2) 
 1 to 2 years ago (3) 
 More than 2 years ago (4) 
 N/A (5) 
 
Q3.3 Please indicate your primary reason(s) for seeking treatment. Check all that apply. 
 Anxiety (1) 
 Depression (2) 
 Problems adjusting to life problems (breakup, divorce, loss of loved one, etc.) (3) 
 Physiological problems (fatigue, unusual sleep patterns, changes in appetite, bodily aches, etc.) (4) 
 Prefer not to answer (5) 
 Not sure (6) 
 Other (please specific) (7) ____________________ 
 
Q3.4 Please indicate your formal diagnosis by a professional service provider. Check all that apply. 
 Adult Deficit Hyperactivity Disorder (ADHD) (1) 
 Bipolar Disorder (2) 
 Depression NOS (3) 
 Dysthymia (4) 
 Generalized Anxiety Disorder (GAD) (5) 
 Major Depressive Disorder (MDD) (6) 
 Obsessive-Compulsive Disorder (OCD) (7) 
 Post-Traumatic Stress Disorder (PTSD) (8) 
 Specific Phobia (please specific which type) (9) ____________________ 
 Social Phobia/Social Anxiety Disorder (10) 
 Prefer not to answer (11) 
 Not sure (12) 
 Other (please specify) (13) ____________________ 
 
50 
 
Q3.5 If you sought help from a source other than a professional service provider or you sought help in addition 
to a professional service provider for mental health problems, please indicate which ones below. Check all that 
apply.  
 Friends (1) 
 Family (2) 
 Romantic partner (e.g., boyfriend or girlfriend) (3) 
 Pastor/minister (4) 
 Co-workers (5) 
 Acupuncture (6) 
 Acupressure (7) 
 Yoga (8) 
 Alternative medicine (9) 
 I only sought help from professional providers. (10) 
 Other (please specify) (11) ____________________ 
 
Answer If If you sought help from a source other than a professiona... Family Is Selected  
Q3.6 Please indicate which family member(s) you sought for help. Check all that apply.  
 Grandfather (1) 
 Grandmother (2) 
 Father (3) 
 Mother (4) 
 Spouse (husband/wife) (5) 
 Brother (6) 
 Sister (7) 
 Cousin (8) 
 Other (please specify) (9) ____________________ 
 
Q3.7 When was the last time you reached out to a non-professional source for help? 
 In the last 6 months (1) 
 Between 7 months and 1 year ago (2) 
 1 to 2 years ago (3) 
 More than 2 years ago (4) 
 
Q3.8 Directions: Please choose your answer on a scale from 1 to 5 with 1 being very dissatisfied and 5 being very 
satisfied. If you did not receive medications or psychotherapy/counseling, then check Not Applicable next to the 
appropriate box. If your answer is 1, please still click on that number or your answer will not be registered. 
______ How satisfied are you with the effectiveness of the medications that you received, if any? (1) 
______ How satisfied are you with the effectiveness of the psychotherapy or counseling that you received, if any? (2) 
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Answer If Please choose your answer on a scale from 1 to 5 with 1 b... How satisfied are you 
with the effectiveness of the medications that you received, if any? Is Greater Than or Equal to  
1 
Q3.9 Please explain, in a few sentences, why you gave the rating that you did for your satisfaction level with the 
effectiveness of the medications that you received. Click the next >> button when you are done. 
 
Answer If Please choose your answer on a scale from 1 to 5 with 1 b... How satisfied are you 
with the effectiveness of the psychotherapy or counseling that you received, if any? Is Greater 
Than or Equal to  1 
Q3.10 Please explain, in a few sentences, why you gave the rating that you did for your satisfaction level with the 
effectiveness of the psychotherapy/counseling that you received. Click the next >> button when you are done. 
 
Answer If Have you ever sought medications for emotional or mental ... No Is Selected 
Q4.1 Did you ever think that you would need mental health services, such as medications, for dealing with 
emotional or mental health problems such as feeling sad, blue, anxious, or nervous?  
 Yes (1) 
 No (2) 
 Not sure (3) 
 
Answer If Have you ever sought psychotherapy or counseling for emot... No Is Selected 
Q4.2 Did you ever think that you would need mental health services, such as psychotherapy or counseling, for 
dealing with emotional or mental health problems such as feeling sad, blue, anxious, or nervous?  
 Yes (1) 
 No (2) 
 Not sure (3) 
 
Q5.1 Directions: Please choose your answer on a scale from 1 to 5 with 1 being not at all helpful and 5 being very 
helpful. If your answer is 1, please still click on that number or your answer will not be registered. 
______ How helpful, on average, do you think medication is for people your age who have mental health problems? (1) 
______ How helpful, on average, do you think psychotherapy or counseling is for people your age who have mental 
health problems? (2) 
______ How helpful, on average, do you think both medications AND psychotherapy are for people your age who have 
mental health problems, when they are used together? (3) 
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Q5.2 Please briefly explain your reasoning for giving the rating that you did when you rated the helpfulness of 
medications. 
 
Q5.3 Please briefly explain your reasoning for giving the rating that you did when you rated the helpfulness of 
psychotherapy or counseling. 
 
Q5.4 Please briefly explain your reasoning for giving the rating that you did when you rated the helpfulness of 
both medications and psychotherapy, when they are used together. 
 
Q6.1 The following questions are about your closest friends and family members. Please answer them to the best 
of your knowledge. If you are not sure of any question, just click "Not sure." 
 
Q6.2 How many of your closest friends and family members, excluding yourself, have been formally diagnosed 
with a mental health problem such as depression or anxiety?  
 0 (1) 
 1 (2) 
 2 (3) 
 3+ (4) 
 Not sure (5) 
 
Q6.3 How many of your closest friends and family members, excluding yourself, have had or currently have a 
mental health problem, such as depression or anxiety, but have not been formally diagnosed?  
 0 (1) 
 1 (2) 
 2 (3) 
 3+ (4) 
 Not sure (5) 
 
Q7.1 How many of your closest friends and family members, excluding yourself, have used only medications but 
not psychotherapy or counseling for their mental health problems? 
 0 (1) 
 1 (2) 
 2 (3) 
 3+ (4) 
 Not sure (5) 
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Answer If How many of your closest friends and family members, excl... 1 Is Selected Or How 
many of your closest friends and family members, excl... 2 Is Selected Or How many of your 
closest friends and family members, excl... 3+ Is Selected 
Q7.2 Directions: Please choose your answer on a scale from 1 to 5 with 1 being not at all helpful and 5 being very 
helpful. If your answer is 1, please still click on that number or your answer will not be registered. 
______ In general, how helpful do you think the medications were in contributing to their wellbeing? (1) 
______ To the best of your knowledge, how helpful do they think the medications were in contributing to their 
wellbeing? (2) 
 
Q7.3 How many of your closest friends and family members, excluding yourself, have used only 
psychotherapy/counseling but not medications for their mental health problems?  
 0 (1) 
 1 (2) 
 2 (3) 
 3+ (4) 
 Not sure (5) 
 
Answer If How many of your closest friends and family members, excl... 1 Is Selected Or How 
many of your closest friends and family members, excl... 2 Is Selected Or How many of your 
closest friends and family members, excl... 3+ Is Selected 
Q7.4 Directions: Please choose your answer on a scale from 1 to 5 with 1 being not at all helpful and 5 being very 
helpful. If your answer is 1, please still click on that number or your answer will not be registered. 
______ In general, how helpful do you think the psychotherapy or counseling was in contributing to their wellbeing? 
(1) 
______ To the best of your knowledge, how helpful do they think the psychotherapy or counseling was in contributing 
to their wellbeing? (2) 
 
Q7.5 How many of your closest friends and family members, excluding yourself, have used BOTH 
psychotherapy AND medications for their mental health problems?  
 0 (1) 
 1 (2) 
 2 (3) 
 3+ (4) 
 Not sure (5) 
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Answer If How many of your closest friends and family members, excl... 1 Is Selected Or How 
many of your closest friends and family members, excl... 2 Is Selected Or How many of your 
closest friends and family members, excl... 3+ Is Selected 
Q7.6 Directions: Please choose your answer on a scale from 1 to 5 with 1 being not at all helpful and 5 being very 
helpful. If your answer is 1, please still click on that number or your answer will not be registered. 
______ In general, how helpful do you think medications AND psychotherapy were (when used together) in 
contributing to their wellbeing? (1) 
______ To the best of your knowledge, how helpful do they think the medications AND psychotherapy were (when 
used together) in contributing to their wellbeing? (2) 
 
Q8.1 For the following questions, think of your closest friend or family member. If you cannot decide on just 
one, pick the person with whom you spend more time. 
 
Q8.2 Who is your closest friend or family member who has used medications and/or psychotherapy?  
 Grandfather (1) 
 Grandmother (2) 
 Father (3) 
 Mother (4) 
 Spouse (5) 
 Child (6) 
 Brother (7) 
 Sister (8) 
 Cousin (9) 
 Friend (10) 
 Romantic partner (11) 
 Other (please specify) (12) ____________________ 
 
Q8.3 Which of the following professional service provider(s) did he or she seek? Check all that apply. 
 Psychologist (1) 
 Psychiatrist (2) 
 Licensed Professional Counselor (3) 
 Licensed Clinical Social Worker (4) 
 Psychiatric Nurse Practitioner (5) 
 Physician/family doctor (6) 
 Registered Nurse (7) 
 Other (please specify) (8) ____________________ 
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Q8.4 How long ago was his or her most recent visit to a professional service provider for help? If you cannot 
remember, you don't know, or if he or she did not seek a professional service provider, check N/A. 
 In the last 6 months (1) 
 Between 7 months to 1 year ago (2) 
 1 to 2 years ago (3) 
 More than 2 years ago (4) 
 N/A (5) 
 
Q8.5 Please indicate his or her primary reason(s) for seeking treatment. Check all that apply. 
 Anxiety (1) 
 Depression (2) 
 Problems adjusting to life problems (breakup, divorce, loss of loved one, etc.) (3) 
 Physiological problems (fatigue, unusual sleep patterns, changes in appetite, bodily aches, etc.) (4) 
 Prefer not to answer (5) 
 Not sure (6) 
 Other (please specific) (7) ____________________ 
 
Q8.6 Please indicate his or her formal diagnosis by a professional service provider. Check all that apply. 
 Adult Deficit Hyperactivity Disorder (ADHD) (1) 
 Bipolar Disorder (2) 
 Depression NOS (3) 
 Dysthymia (4) 
 Generalized Anxiety Disorder (GAD) (5) 
 Major Depressive Disorder (MDD) (6) 
 Obsessive-Compulsive Disorder (OCD) (7) 
 Post-Traumatic Stress Disorder (PTSD) (8) 
 Specific Phobia (please specific which type) (9) ____________________ 
 Social Phobia/Social Anxiety Disorder (10) 
 Prefer not to answer (11) 
 Not sure (12) 
 Other (please specify) (13) ____________________ 
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Q8.7 If he or she sought help from anything other than a professional service provider for mental health 
problems, please indicate which ones below. Check all that apply.  
 Friends (1) 
 Family (2) 
 Romantic partner (e.g., boyfriend or girlfriend) (3) 
 Pastor/minister (4) 
 Co-workers (5) 
 Acupuncture (6) 
 Acupressure (7) 
 Yoga (8) 
 Alternative medicine (9) 
 He or she only sought help from professional providers. (10) 
 Other (please specify) (11) ____________________ 
 
Answer If If he or she sought help from anything other than a profe... Family Is Selected  
Q8.8 Please indicate which family member(s) he or she sought for help. Check all that apply.  
 Grandfather (1) 
 Grandmother (2) 
 Father (3) 
 Mother (4) 
 Spouse (husband/wife) (5) 
 Brother (6) 
 Sister (7) 
 Cousin (8) 
 Not sure (9) 
 Other (please specify) (10) ____________________ 
 
Answer If If he or she sought help from anything other than a profe... He or she only sought help 
from professional providers. Is Not Selected 
Q8.9 When was the last time he or she reached out to a non-professional source of help? 
 In the last 6 months (1) 
 Between 7 months and 1 year ago (2) 
 1 to 2 years ago (3) 
 More than 2 years ago (4) 
 Not sure (5) 
 N/A (6) 
 
Q8.10 Did this close friend or family member affect your decision to seek or not seek treatment in any way? 
Please state either Yes or No then explain in a few sentences. 
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Q9.1 For the following items, please circle an answer from 1 to 5, with 1 being strongly disagree and 5 being 
strongly agree. 
______ I think less of a person who has received mental health treatment. (1) 
______ Most people would willingly accept someone who has received mental health treatment as a close friend. (2) 
______ Most people feel that receiving mental health treatment is a sign of personal failure. (3) 
______ I would willingly accept someone who has received mental health treatment as a close friend. (4) 
______ Most people think less of a person who has received mental health treatment. (5) 
______ I feel that receiving mental health treatment is a sign of personal failure. (6) 
Q10.1 Below is a list of things which can stop, delay or discourage people from getting professional care for a 
mental health problem, or continuing to get help.  By professional care we mean care from such staff as a family 
doctor, community mental health team (e.g. care coordinator, mental health nurse or mental health social 
worker), psychiatrist, counselor, psychologist or psychotherapist.     Have any of these issues ever stopped, 
delayed or discouraged you from getting, or continuing with, professional care for a mental health 
problem?     Please select one number on each row to indicate the answer that best suits you. Note: Even if your 
answer is 0 please click on that number or your answer will be not registered.  For ‘not applicable’ e.g. if it is a 
question about children and you do not have children, please click 0 and write N/A in the provided text box. 
______ Being unsure where to go to get  professional care (1) 
______ Wanting to solve the problem on my own (2) 
______ Concern that I might be seen as weak for having a mental health problem (3) 
______ Fear of being put in hospital against my will (4) 
______ Concern that it might harm my chances when applying for jobs. (please click 0 and type N/A if not applicable) 
(5) 
______ Problems with transportation or travelling to appointments (6) 
______ Thinking the problem would get better by itself (7) 
______ Concern about what my family might think, say, do or feel (8) 
______ Feeing embarrassed or ashamed (9) 
______ Preferring to get alternative forms of care (e.g. traditional / religious healing or alternative / complementary 
therapies) (10) 
______ Not being able to afford the financial costs involved (11) 
______ Concern that I might be seen as ‘crazy’ (12) 
______ Thinking that professional care probably would not help (13) 
______ Concern that I might be seen as a bad parent (please click 0 and type N/A if not applicable) (14) 
______ Professionals from my own ethnic or cultural group not being available (15) 
______ Being too unwell to ask for help (16) 
______ Concern that people I know might  find out (17) 
______ Dislike of talking about my feelings, emotions or thoughts (18) 
______ Concern that people might not take me seriously if they found out I was having professional care (19) 
______ Concerns about the treatments available (e.g. medication side effects) (20) 
______ Not wanting a mental health problem to be on my medical records (21) 
______ Having had previous bad experiences with professional care for mental health (please click 0 and type N/A if 
not applicable) (22) 
______ Preferring to get help from family or friends (23) 
______ Concern that my children may be taken into care or that I may lose access or custody without my agreement 
(please click 0 and type N/A if not applicable) (24) 
______ Thinking I did not have a problem (25) 
______ Concern about what my friends might think, say or do (26) 
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______ Difficulty taking time off work (please click 0 and type N/A if not applicable) (27) 
______ Concern about what people at work might think, say or do (please click 0 and type N/A if not applicable) (28) 
______ Having problems with childcare while I receive professional care (please click 0 and type N/A if not 
applicable) (29) 
______ Having no one who could help me get professional care (30) 
 
Q10.2 If you have any additional thoughts or comments about attitudes, beliefs, and behaviors toward treatment 
seeking, please provide them in the empty space below.  
 
Q10.3 Thank you for your participation. 
 
 
